Komori
Results7061Japan Hospice Holdings Inc.Information and Communications, Services and Others

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

Cumulative revenue through September 2026 exceeded the year-earlier period, while operating profit halved and ordinary profit and net profit turned from profit to loss. The company stated that it would not provide figures for its full-year earnings forecast or dividend forecast until a reasonable forecast could be made.

Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
50.2
% (year-on-year decrease in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026 to 30 September 2026ConsolidatedJapanese GAAP
Net Sales10,712Millions of yenYear on year +3.4%
Operating profit349Millions of yenYear on year -50.2%
Ordinary income-23Millions of yen
Net income attributable to owners of the parent-75Millions of yen

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.

Net income per share-¥8.91
Financial position at period-end
Total assets18,462Millions of yen
of which net assets 3,419 Millions of yenEquity ratio 18.5%vs. prior year-end -0.9pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Revision to Earnings ForecastNot disclosed → Not disclosed
Annual Dividend Forecast25 Yen → Undetermined
Factors Behind Changes in Business Performance

The decline in medical insurance revenue resulting from the revision of medical service fees; the decrease in users following the normalisation of the price range for housing rents and other charges; and the increase in personnel expenses as a percentage of revenue because the decline in the number of employees was smaller than the decline in users. Improvements in the collection rate for Life Plan fees and facility line utilisation contributed to higher revenue.

Disclosure regarding the going concern assumption

No applicable items

Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidationAdded: 0 companies; removed: 0 companies (company names: —)
Material subsequent eventsNo applicable matters
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of stock acquisition rights — none in the current period / Extraordinary loss Not disclosed
Depreciation and amortization435,075 Thousands of yen
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End8,484,100 shares
Treasury Shares at Period-End1,490 shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026 to 30 September 2026
Net Sales10,712 Millions of yen (YoY +3.4%)
Operating profit349 Millions of yen (YoY -50.2%)
Ordinary income-23 Millions of yen
Profit attributable to owners of the parent-75 Millions of yen
Net income per share-¥8.91
Equity ratioEnd of the current fiscal period 18.5 / End of previous period 19.4
Total assets18,462 Millions of yen
Net assets3,419 Millions of yen
Revision to Earnings ForecastNot disclosed → Not disclosed
Annual Dividend Forecast25 Yen → Undetermined
Depreciation and amortization435,075 Thousands of yen
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of stock acquisition rights — none in the current period / Extraordinary loss Not disclosed
Disclosure regarding the going concern assumptionNo applicable items
Change in accounting policyChanges due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None
Changes in the scope of consolidationAdded: 0 companies; removed: 0 companies (company names: —)
Material subsequent eventsNo applicable matters
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results BriefingNone (対象者:Not disclosed)
Issued Shares at Period-End8,484,100 shares
Treasury Shares at Period-End1,490 shares
Factors Behind Changes in Business PerformanceThe decline in medical insurance revenue resulting from the revision of medical service fees; the decrease in users following the normalisation of the price range for housing rents and other charges; and the increase in personnel expenses as a percentage of revenue because the decline in the number of employees was smaller than the decline in users. Improvements in the collection rate for Life Plan fees and facility line utilisation contributed to higher revenue.
Items this document does not state (13)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Immediately after the revision of medical service fees, medical insurance revenue per resident decreased by approximately ¥200,000 per month. Returning housing rents and other charges to their previous price range reduced the number of users by 162, from 1,393 to 1,231. Because the decrease in the number of employees was smaller than the decline in users, personnel expenses as a percentage of revenue increased. Meanwhile, measures such as improving the collection rate for Life Plan fees and increasing facility line utilisation contributed effectively.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | Japan Hospice Holdings Inc. (7061) timely disclosure | Komori